Diabetes Drug Lawsuits Over Pancreatic Cancer Risk Dismissed, Again
The U.S. District Judge presiding over all federal lawsuits involving pancreatic cancer diagnosed among users of Byetta, Januvia, Victoza and other incretin mimetic-based diabetes drugs has granted a motion for summary judgment brought by the manufacturers, dismissing the claims again, after a similar ruling issued several years ago was overturned on appeal.
There are currently about 1,000 Byetta lawsuits, Januvia lawsuits, Janumet lawsuits, and Victoza lawsuits pending in the federal court system, which have been centralized in the U.S. District Court for the Southern District of California since 2013, as part of a multidistrict litigation (MDL).
The drugs are all part of a popular class of diabetes medications, known as incretin mimetics, which were linked to a potential risk of pancreatitis about a decade ago. The pancreatic cancer litigation emerged as a growing number of former users filed lawsuits alleging that the failure to warn about the side effects associated with Byetta, Januvia and other incretin mimetics resulted in the development of pancreatic cancer, which may have been avoided if earlier warnings and information had been provided to consumers and the medical community.
Did You Know?
Millions of Philips CPAP Machines Recalled
Philips DreamStation, CPAP and BiPAP machines sold in recent years may pose a risk of cancer, lung damage and other injuries.Learn More
Given common questions of fact and law raised in complaints filed throughout the federal court system, the litigation was centralized before U.S. District Judge Anthony Battaglia for coordinated discovery and pretrial proceedings.
In 2015, Judge Battaglia issued an order that dismissed all claims in the MDL, after determining the lawsuits were preempted by federal law. The Court found at that time there was sufficient evidence to establish the FDA would not have approved any request by the drug makers to add an earlier pancreatic cancer warnings to the drug labels, which allowed the drug makers to escape liability in state-law based failure to warn claims.
Following a lengthy appeal process, the U.S. Court of Appeals for the Ninth Circuit overturned that ruling in December 2017, reinstating the diabetes drug lawsuits, and returning the cases back to Judge Battaglia for further discovery and proceedings.
Over the past few years, hundreds of additional cases have been added to the litigation and Judge Battaglia established a pretrial schedule that resulted in another round of motions for summary judgment on the pre-emption issue before any individual cases were prepared for trial.
In an omnibus order (PDF) issued on March 9, Judge Battaglia determined one again that the cases should be dismissed, granting defendants summary judgment, indicating plaintiffs could not bring substantial and reliable arguments showing that the drugs caused pancreatic cancer.
“As previously analyzed, the opinions of Plaintiffs’ experts are unreliable and therefore do not constitute admissible evidence,” he wrote. “With no expert evidence to show a causal relationship between incretin-based therapies and pancreatic cancer, Plaintiffs cannot demonstrate a genuine dispute of material fact as to the element of general causation.”
Unless plaintiffs can mount another success appeal, this ruling is likely to mean the end of the litigation.
VirginiaMay 17, 2022 at 11:25 am
My sweet 69 year old diabetic mother died November 2021 due to take Ozempic. I am devastated.
JoannSeptember 3, 2021 at 8:28 pm
I feel that there is something wrong here my husband lost his life because of this drug and now my heart ach for him I wonder this would of happened to his love one I sure he would not feel this way I watch my husband suffer and cry out in pain And not be able to speak a word shame on you judge You let us all down
DaymondAugust 21, 2021 at 1:06 am
Januvia use fatty liver disease
KathyAugust 9, 2021 at 3:17 am
I can’t believe hundreds of people either lost a loved one or became very sick and a judge throws out these cases ? All these people took Byetta or a similar type. That’s not proof enough? So now we have no case ? Unbelievable!
JuanitaJuly 3, 2021 at 6:53 pm
I lost my beloved spouse 2/29/214, do to taking this dreadful Byetta drug. He had no other problems until he started taking this drug. How could a judged dismiss a case. Like the judge in who you voted for to help the people who suffer do to a deadly drug. Since the lost of my spouse my life has been turn upside down. I have had to go for therapy and are taking medication now. What if you have [Show More]I lost my beloved spouse 2/29/214, do to taking this dreadful Byetta drug. He had no other problems until he started taking this drug. How could a judged dismiss a case. Like the judge in who you voted for to help the people who suffer do to a deadly drug. Since the lost of my spouse my life has been turn upside down. I have had to go for therapy and are taking medication now. What if you have had a lost do to drugs. My husband follow the direct instructions for the medication. Help me please to try to get back my life. God helps me through my breaks downs, sometimes it seen likes he just died!
VeldaJune 13, 2021 at 7:05 pm
Not a comment, but a question. Have the plaintiffs in this case filed for an appeal again? If not,are there any plans for an appeal in the works?
"*" indicates required fields
More Top Stories
A Wegovy gastroparesis lawsuit blames the weight loss drug for a stomach paralysis problems which left a woman with permanent injuries.
Uber faces a lawsuit from four passengers who say they were sexually assaulted by drivers, due to the company's lack of security measures and focus on passenger safety.
A Bard PowerPort lawsuit claims the defective design of the port catheter led to a woman developing a severe infection and needing to have the implant surgically removed.